- Joined
- May 2, 2005
- Messages
- 2,027
- Reaction score
- 749
I originally put it in pain med but it’s probably better here.
I thought I understood the core tenets of harm reduction and strongly support them but I was “educated” on Twitter a bit ago about HR in setting of chronic pain. The CPPs and some HR providers feel it is inappropriate to have these patients to taper off/down on opiate doses or switch to MAT. HR principles support maintaining these patients on large doses of opiates because they are stable on them These are obviously the most vocal patients/advocates and they are the exception to the statistical conclusion. They referenced a new NEJM paper showing tapers result on suicide and other negative outcomes.
Maybe my thinking is dated but AFAIK opiates for chronic pain are not supported especially for things like EDS and Fibro, and it’s reckless to allow them to continue on large doses opiates despite a lack of clinical support.
I thought I understood the core tenets of harm reduction and strongly support them but I was “educated” on Twitter a bit ago about HR in setting of chronic pain. The CPPs and some HR providers feel it is inappropriate to have these patients to taper off/down on opiate doses or switch to MAT. HR principles support maintaining these patients on large doses of opiates because they are stable on them These are obviously the most vocal patients/advocates and they are the exception to the statistical conclusion. They referenced a new NEJM paper showing tapers result on suicide and other negative outcomes.
Maybe my thinking is dated but AFAIK opiates for chronic pain are not supported especially for things like EDS and Fibro, and it’s reckless to allow them to continue on large doses opiates despite a lack of clinical support.